Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PRPH | US
0.29
12.08%
Healthcare
Drug Manufacturers - Major
30/06/2024
30/08/2024
2.69
2.47
2.76
2.40
ProPhase Labs Inc. engages in the development and commercialization of novel drugs dietary supplements and compounds in the United States. The company operates in two segments Diagnostic Services and Consumer Products. It provides a range of OTC dietary supplements including Legendz XL for male sexual health; and Triple Edge XL an energy and stamina booster. The company also offers contract manufacturing services such as consumer product development pre-commercialization production warehousing and distribution; COVID-19 diagnostic information services to a range of customers including health plans third party payers and government organizations; and respiratory pathogen panel molecular testing services as well as personal genomics products and services. In addition it is involved in the research development manufacture distribution marketing and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs Inc. was founded in 1989 and is headquartered in Garden City New York.
View LessLow Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
128.5%1 month
114.7%3 months
78.6%6 months
81.3%-
10.09
1.16
0.61
0.29
2.45
4.25
-
-27.01M
51.32M
51.32M
-
-316.37
-95.20
-81.30
-50.92
10.07
1.73
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.83
Range1M
1.19
Range3M
3.18
Rel. volume
0.81
Price X volume
68.55K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
NanoViricides Inc | NNVC | Drug Manufacturers - Major | 1.95 | 23.04M | 3.72% | n/a | 0.00% |
TherapeuticsMD Inc | TXMD | Drug Manufacturers - Major | 1.885 | 21.74M | 0.27% | n/a | 27.44% |
China Pharma Holdings Inc | CPHI | Drug Manufacturers - Major | 0.2019 | 3.47M | -3.40% | n/a | 54.76% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Fathom Holdings Inc | FTHM | Real Estate Services | 2.64 | 55.46M | -0.38% | n/a | 36.20% |
Flux Power Holdings Inc | FLUX | Electronic Components | 3.27 | 54.55M | -4.39% | n/a | 298.63% |
LightPath Technologies Inc | LPTH | Electronic Components | 1.29 | 50.06M | -0.77% | n/a | 33.91% |
Pioneer Power Solutions Inc | PPSI | Electronic Components | 4.29 | 46.83M | 0.94% | n/a | 8.54% |
Comstock Mining Inc | LODE | Real Estate Services | 0.2588 | 45.36M | 21.62% | 3.23 | 14.37% |
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 3.68 | 39.85M | -1.12% | n/a | 54.96% |
RF Industries Ltd | RFIL | Electronic Components | 3.77 | 39.06M | 2.18% | n/a | 88.58% |
The InterGroup Corporation | INTG | Real Estate Services | 17.7 | 38.71M | -0.28% | n/a | -257.98% |
Interlink Electronics Inc | LINK | Electronic Components | 3.7897 | 37.38M | -6.11% | n/a | 7.29% |
Nortech Systems Incorporated | NSYS | Electronic Components | 12.32 | 34.03M | -1.60% | 5.50 | 49.22% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 2.45 | - | Cheaper |
Ent. to Revenue | 4.25 | - | Cheaper |
PE Ratio | - | 38.66 | - |
Price to Book | 1.16 | 10.88 | Cheaper |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 78.58 | - | Riskier |
Debt to Equity | 0.61 | 1.63 | Cheaper |
Debt to Assets | 0.29 | 0.32 | Par |
Market Cap | 51.32M | - | Emerging |